More than a decade ago, a neuroscience research group began homing in on a gene discovered in roundworms for its intriguing links to dopamine signaling.
The group has since shown the human version of the same gene may hold clues for new treatments for multiple brain disorders ranging from addiction to Alzheimer鈥檚 disease.
Now, with the help of more than $600,000 in new grants, these 卧龙资源网 researchers hope to add glioblastoma, the most aggressive form of brain cancer, to that list.
The gene, called MBLAC1, was first fingered as an important molecule for cellular signaling and health by neuroscience experts in the lab of Randy D. Blakely, Ph.D, executive director of Florida Atlantic鈥檚 Stiles-Nicholson Brain Institute.
For the glioblastoma project, the Blakely lab has joined forces with the lab of Gregg B. Fields, Ph.D., vice president for research and executive director of the Institute for Human Health and Disease Intervention (I-Health) at Florida Atlantic. Ania Knapinska, Ph.D., research professor in Florida Atlantic鈥檚 Charles E. Schmidt College of Science, I-Health member, and Fields鈥 collaborator, is the principal investigator.
The work is supported by $562,000 from the Florida Department of Health鈥檚 Cancer Connect program and a $50,000 grant from Palm Health Foundation.
The Blakely lab previously found that the protein expressed by the roundworm version of MBLAC1 protein works in a novel way to sustain appropriate levels of copper, a vital micronutrient that is tightly linked to processes of energy creation.
鈥淭his protein is fundamentally controlling the ability of cells to produce energy,鈥 Blakely said. 鈥淲e know that cancer cells are dependent on a maintained source of energy because they鈥檙e growing rapidly and metastasizing. These are very energydemanding changes.鈥
The labs are collaborating to explore how eliminating the gene or its downstream support for copper homeostasis and energy production affects the growth and spread of glioblastoma tumors. Their tools include a mouse model developed by Blakely that precludes MBLAC1.
The plan also includes the development of a method to rapidly screen drugs for the ability to block MBLAC1 activity. The effort aims to find ways to limit glioblastoma spread and add years of life to those affected with this deadly cancer.